When a regulatory submission runs into delays, the first suspect is usually the science. In practice, much of the friction comes from the documents themselves: summaries that don’t make the case, numbers that differ between sections, and statements a reviewer can’t trace back to data. Each of these can lead to questions from FDA, EMA […]